7xm download apk
Cyber Monday is over, but Lululemon just dropped a ton of new We Made Too Much finds — 20+ best belt bags, sweaters, leggings and more (starting under $30!)
Estonia's top spy says NATO must deter Russia for next 10 to 20 years
Sean ‘Diddy’ Combs’ third bid to be released on bail won’t be decided until next week
Biden’s pardon of son risks tarnishing legacy, empowering Trump
‘Saudi Arabia’s Vision 2030 to create vast opportunities for Indian companies’
Share this Story : Police ask for help as they look for man, 67, missing since Nov. 24 Copy Link Email X Reddit Pinterest LinkedIn Tumblr Breadcrumb Trail Links Local News Police ask for help as they look for man, 67, missing since Nov. 24 Police indicated Leroux frequents the St. Laurent Blvd. and Montreal Road areas and may have travelled to Embrun. Author of the article: Staff Reporter Published Dec 02, 2024 • Last updated 24 minutes ago • 1 minute read Join the conversation You can save this article by registering for free here . Or sign-in if you have an account. The Ottawa Police Service Missing Persons Section is seeking the public's assistance in locating missing 67-year-old Joseph Rene Leroux. Photo by Supplied / OTTAWA POLICE SERVICE Article content The Ottawa police are asking for the public’s assistance in locating a 67-year-old man who has been missing since Nov. 24. Article content Article content Joseph Rene Leroux was last seen leaving his residence in the Glen Cairn neighbourhood at about 8 p.m. more than a week ago, police said in a news release Dec. 2. He has a medical condition that requires medication and there are concerns for his well-being, they said. Advertisement 2 Story continues below This advertisement has not loaded yet, but your article continues below. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Exclusive articles from Elizabeth Payne, David Pugliese, Andrew Duffy, Bruce Deachman and others. Plus, food reviews and event listings in the weekly newsletter, Ottawa, Out of Office. Unlimited online access to Ottawa Citizen and 15 news sites with one account. Ottawa Citizen ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles, including the New York Times Crossword. Support local journalism. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Exclusive articles from Elizabeth Payne, David Pugliese, Andrew Duffy, Bruce Deachman and others. Plus, food reviews and event listings in the weekly newsletter, Ottawa, Out of Office. Unlimited online access to Ottawa Citizen and 15 news sites with one account. Ottawa Citizen ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles, including the New York Times Crossword. Support local journalism. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors Sign In or Create an Account Email Address Continue or View more offers If you are a Home delivery print subscriber, online access is included in your subscription. Activate your Online Access Now Article content Police indicated Leroux frequents the St. Laurent Blvd. and Montreal Road areas and may have travelled to Embrun. He was described as white, with a slim build and grey and black hair. No details about the clothes he was wearing at the time of his disappearance were available. Anyone with information about his whereabouts was asked to call police at 613-236-1222. Anonymous tips can be submitted by calling Crime Stoppers toll-free at 1-800-222-8477 or at crimestoppers.ca . Our website is your destination for up-to-the-minute news, so make sure to bookmark our homepage and sign up for our newsletters so we can keep you informed. Recommended from Editorial OPP East Region charges 23 drivers in RIDE program's first week Three charged after youth abducted, held for ransom in Orléans Article content Share this article in your social network Share this Story : Police ask for help as they look for man, 67, missing since Nov. 24 Copy Link Email X Reddit Pinterest LinkedIn Tumblr Comments You must be logged in to join the discussion or read more comments. Create an Account Sign in Join the Conversation Postmedia is committed to maintaining a lively but civil forum for discussion. Please keep comments relevant and respectful. Comments may take up to an hour to appear on the site. You will receive an email if there is a reply to your comment, an update to a thread you follow or if a user you follow comments. Visit our Community Guidelines for more information. Trending Layoffs could be on the table for public servants. Here's everything you need to know Public Service City of Ottawa worker fired after audit uncovers kickback scheme with landlords Local News Battle lines drawn between public servants, taxpayers over public service pension surplus Public Service Is Ottawa ready for the return of former Senators winger Dany Heatley? Ottawa Senators Today's letters: Get the campers out of Ottawa parks Opinion Read Next Latest National Stories Featured Local SavingsGlobal Blockchain Technologies (CVE:BLOC) Stock Price Up ∞ – Should You Buy?
Star quits rugby to chase NFL dreamAgrochemicals Market Poised for Significant Growth, Projected to Reach $282.2 Billion by 2028
SAN DIEGO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that the Company is scheduled to present at the following upcoming investor conferences. About Capricor Therapeutics Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. At the forefront of our innovation is our lead product candidate, deramiocel (CAP-1002), an allogeneic cardiac-derived cell therapy. Extensive preclinical and clinical studies have shown deramiocel to demonstrate immunomodulatory, antifibrotic, and regenerative actions specifically tailored for dystrophinopathies and heart disease. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Capricor is also harnessing the power of its exosome technology, using its proprietary StealthXTM platform in preclinical development focused on the areas of vaccinology, targeted delivery of oligonucleotides, proteins and small molecule therapeutics to potentially treat and prevent a diverse array of diseases. At Capricor, we stand committed to pushing the boundaries of possibility and forging a path toward transformative treatments for those in need. For more information, visit capricor.com , and follow Capricor on Facebook , Instagram and Twitter . Cautionary Note Regarding Forward-Looking Statements Statements in this press release regarding the efficacy, safety, and intended utilization of Capricor's product candidates; the initiation, conduct, size, timing and results of discovery efforts and clinical trials; the pace of enrollment of clinical trials; plans regarding regulatory filings, future research and clinical trials; regulatory developments involving products, including the ability to obtain regulatory approvals or otherwise bring products to market; manufacturing capabilities; dates for regulatory meetings; statements about our financial outlook; the ability to achieve product milestones and to receive milestone payments from commercial partners; plans regarding current and future collaborative activities and the ownership of commercial rights; potential future agreements; scope, duration, validity and enforceability of intellectual property rights; future revenue streams and projections; expectations with respect to the expected use of proceeds from the recently completed offerings and the anticipated effects of the offerings; and any other statements about Capricor's management team's future expectations, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "believes,” "plans,” "could,” "anticipates,” "expects,” "estimates,” "should,” "target,” "will,” "would” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements. More information about these and other risks that may impact Capricor's business is set forth in Capricor's Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission on March 11, 2024, and in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, as filed with the Securities and Exchange Commission on November 14, 2024. All forward-looking statements in this press release are based on information available to Capricor as of the date hereof, and Capricor assumes no obligation to update these forward-looking statements. Capricor has entered into an agreement for the exclusive commercialization and distribution of deramiocel (CAP-1002) for DMD in the United States and Japan with Nippon Shinyaku Co., Ltd. (U.S. subsidiary: NS Pharma, Inc.), subject to regulatory approval. Deramiocel is an Investigational New Drug and is not approved for any indications. None of Capricor's exosome-based candidates have been approved for clinical investigation. For more information, please contact: Capricor Media Contact: Raquel Cona KCSA Strategic Communications [email protected] 212.896.1204 Capricor Company Contact: AJ Bergmann, Chief Financial Officer [email protected] 858.727.1755
The wait is over, Golden State. The newest WNBA franchise is here, coming to Chase Center in 2025. Welcome to the league, Valkyries. Leading the way will be Natalie Nakase, a former assistant and two-time league champion with the Aces. Her coaching includes the rare feat of international experience with Nakase spending four total seasons in Germany and Japan. She followed it up with five seasons in the NBA as an assistant for the Clippers. California born and California raised, Nakase will now try to make her mark in California women's sports history. The Valkyries couldn't have picked a better time to join the league. The WNBA is on track for their biggest season yet after a historic year in 2024. But with more teams, more games and more players, the W is now bigger and better than before. As the Valkyries begin their golden season, there's no time like the now to be part of the action. Here's how to get the best tickets for every Golden State game in 2025. BUY NOW : Get tickets to first Valkyries WNBA season in 2025 Valkyries tickets 2025 Tickets : StubHub Tickets for 2025 Valkyries game are available now on StubHub . Golden State fans are beyond ready for the newest WNBA franchise. The Valkyries season opener against the Sparks currently has a get-in price of $319. When they host the Fever in June, tickets are a bit cheaper, priced at $263. Prices may fluctuate as more passes are added and time until tipoff ticks down. Click the link below to view more prices and seats. BUY NOW : Best prices, seats for Valkyries games on StubHub Chase Center seating chart StubHub Valkyries schedule 2025 The Valkyries make their franchise debut on May 16 agains the Sparks. They'll have 44 total games in 2025, wrapping up on Sept. 11 in Minnesota. There's plenty of time for fans to catch Golden State in its inaugural WNBA season. Here's a look at the full schedule of games. Date Game Time (ET) Tickets Fri., May 16 vs. Sparks 10 p.m. Buy now Wed., May 21 vs. Mystics 10 p.m. Buy now Fri., May 23 at Sparks 10 p.m. Buy now Tues., May 27 at Liberty 7 p.m. Buy now Thurs., May 29 at Liberty 7 p.m. Buy now Sun., June 1 vs. Lynx* 8:30 p.m. Buy now Thurs., June 5 at Mercury* 10 p.m. Buy now Sat., June 7 vs. Aces* 3 p.m. Buy now Mon., June 9 at Sparks* 10 p.m. Buy now Sat., June 14 vs. Storm* 8:30 p.m. Buy now Tues., June 17 at Wings* 8 p.m. Buy now Thurs., June 19 vs. Fever 10 p.m. Buy now Sun., June 22 vs. Sun 8:30 p.m. Buy now Wed., June 25 vs. Liberty 10 p.m. Buy now Fri., June 27 vs. Sky 10 p.m. Buy now Sun., June 29 vs. Storm 8:30 p.m. Buy now Sat., July 5 at Lynx 8 p.m. Buy now Mon., July 7 at Dream 7:30 p.m. Buy now Wed., July 9 at Fever Noon Buy now Sat., July 12 at Aces 4 p.m. Buy now Mon., July 14 vs. Mercury 10 p.m. Buy now Wed., July 16 at Storm 3 p.m. Buy now July 18-19 WNBA All-Star – – Fri., July 25 vs. Wings 10 p.m. Buy now Sun., July 27 at Sun 1 p.m. Buy now Tues., July 29 at Dream 7:30 p.m. Buy now Thurs., July 31 at Mystics 7:30 p.m. Buy now Fri., Aug. 1 at Sky 7:30 p.m. Buy now Sun., Aug. 3 at Aces 6 p.m. Buy now Wed., Aug. 6 vs. Aces 10 p.m. Buy now Sat., Aug. 9 vs. Sparks 3 p.m. Buy now Mon., Aug. 11 vs. Sun 10 p.m. Buy now Wed., Aug. 13 at Mystics 7:30 p.m. Buy now Fri., Aug. 15 at Sky 7:30 p.m. Buy now Sun., Aug. 17 vs. Dream 8:30 p.m. Buy now Tues., Aug. 19 vs. Mercury 10 p.m. Buy now Fri., Aug. 22 at Mercury 10 p.m. Buy now Sun., 24 at Wings 4 p.m. Buy now Sat., Aug. 30 vs. Mystics 8:30 p.m. Buy now Sun., Aug. 31 vs. Fever 8:30 p.m. Buy now Tues., Sept. 2 vs. Liberty 10 p.m. Buy now Thurs., Sept. 4 vs. Wings 10 p.m. Buy now Sat., Sept. 6 vs. Lynx 8:30 p.m Buy now Tues., Sept. 9 at Storm 10 p.m. Buy now Thurs., Sept. 11 at Lynx 8 p.m. Buy now *Commissioner's Cup game If you purchase a product or register for an account through one of the links on our site, we may receive compensation. Learn more >
ECA Board concludes 2024 with focus on strategic priorities for 2025 and beyondBOCA RATON, Fla. (AP) — Florida Atlantic is finalizing the hiring of Texas Tech offensive coordinator Zach Kittley as its new head coach, a person with knowledge of the decision said Monday. Kittley and the school were working through the remaining details Monday, said the person, who spoke to The Associated Press on condition of anonymity because the school has yet to announce that the hiring is complete. The Owls are replacing Tom Herman, who was fired two weeks ago with two games left in his second year at the school. Kittley had stints as offensive coordinator at Houston Baptist and Western Kentucky before returning to Texas Tech — his alma mater — in 2022 in the same role. The Red Raiders have averaged 435 yards per game over the last three seasons under Kittley, 22nd best among all FBS teams. This season saw the Red Raiders rank among the nation's best offenses: They were eighth in yards per play, eighth in points per game, 10th in yards per game and did all that at a pace nearly unmatched nationally. Texas Tech averaged 78.25 plays per game this season, just behind Syracuse's 78.33 for the national lead. As a student assistant, then graduate assistant and assistant quarterbacks coach at Texas Tech, Kittley helped coach Patrick Mahomes — the Kansas City Chiefs star, NFL MVP and Super Bowl champion — during his collegiate career. The Owls went 3-9 this season, their fourth consecutive losing record. Lane Kiffin went 27-13 with two bowl wins in his three seasons at FAU; the Owls are 22-35 in five seasons since Kiffin left for Ole Miss after the 2019 campaign. Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-football